Trial Profile
A prospective, randomized, single blind, parallel, active controlled, multicentre, non-inferiority, phase III clinical study to evaluate the immunogenicity and safety of single-dose and multi-dose vials of Measles Mumps and Rubella vaccine (Live) (Freeze-dried) of M/s Cadila Healthcare Limited compared to Measles Mumps and Rubella vaccine (Live) (Freeze-dried) of M/s Serum Institute of India Limited in healthy paediatric subjects aged 15-18 months
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Dec 2018
Price :
$35
*
At a glance
- Drugs Measles mumps and rubella virus vaccine (Primary)
- Indications Measles; Mumps; Rubella
- Focus Registrational; Therapeutic Use
- Sponsors Cadila Healthcare
- 17 Mar 2016 New trial record